NAT10 and colorectal cancer: Previous studies have shown that using CRISPR/Cas9 technology to completely knock out NAT10 in colorectal cancer cells can lead to cell death, demonstrating that NAT10 is essential for the proliferation of colorectal cancer cells [15].